10 Best Healthcare Stocks to Buy According to Hedge Funds
Healthcare has rarely been short of investment opportunities, but deciding where to look has become more complicated.
Abbott Laboratories (ABT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 10,897,178 | $988,809,932 | +98% | 0.44% |
| 2. | Citadel Investment Group Ken Griffin | 8,597,227 | $780,112,378 | +349% | 0.09% |
| 3. | Marshall Wace LLP Paul Marshall And Ian Wace | 5,542,438 | $502,920,825 | +176% | 0.4% |
| 4. | Diamond Hill Capital Ric Dillon | 4,936,774 | $447,962,873 | -9% | 3.59% |
| 5. | AQR Capital Management Cliff Asness | 4,193,058 | $380,478,062 | +167% | 0.13% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $86.82 | 2,000 | $173,640.00 | 23,319 | 2026-05-07 | Filing | |
| $92.65 | 10,000 | $926,537.00 | 6,751,103 | 2026-04-27 | Filing | |
| $91.50 | 2,200 | $201,300.00 | 2,200 | 2026-04-23 | Filing | |
| $108.33 | 5,033 | $545,238.98 | 6,738,817 | 2026-02-04 | Filing | |
| $109.14 | 4,967 | $542,092.42 | 6,733,784 | 2026-02-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $109.54 | 27 | $2,957.58 | 24,549 | 2026-09-02 | Filing | |
| $116.19 | 180,297 | $20,948,708.43 | 306,461 | 2026-08-25 | Filing | |
| $115.57 | 218,535 | $25,256,089.95 | 486,758 | 2026-08-25 | Filing | |
| $109.83 | 5,850 | $642,505.50 | 70,724 | 2026-08-11 | Filing | |
| $115.58 | 709 | $81,946.22 | 39,164 | 2026-03-02 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 102,483 | $10,128,405 | 0.73% | |
| 2. | 47,695 | $4,713,679 | 0.35% | |
| 3. | 14,067 | $1,390,242 | 0.13% | |
| 4. | 8,509 | $840,944 | 0.18% | |
| 5. | 1,749 | $172,854 | 0.1% |
News See All
Gilead vs. Abbott: Which Dividend Healthcare Stock Offers the Better Risk-Reward?
Gilead Sciences, Inc. (NASDAQ:GILD) and Abbott Laboratories (NYSE:ABT) both return cash to shareholders through dividends, but the businesses supporting those payouts look very different.
Abbott Laboratories (ABT) is Facing Segment Competition and Sluggish Nutrition Recovery
Tributary Capital Management released its second-quarter 2026 investor letter for “Multi Cap Core Equity Strategy”. You can download a copy of the letter here.
What Makes Abbott Laboratories (ABT) an Attractive Opportunity?
Focus Wealth Management released its Q2 2026 investor letter. You can download a copy of the letter here.
10 Best Dividend Kings To Buy According to Hedge Funds
The Federal Reserve raised interest rates by 25 basis points on September 16, taking its target range to 3.75%-4%. It was the first rate hike since 2023.
Abbott Faces $384 Million Cost as Infant Formula Legal Risks Persist
Abbott Laboratories (NYSE:ABT) has agreed to pay more than $384 million to resolve U.S.
SCHD vs. VIG: Which Dividend ETF Has the Edge in 2026?
The Schwab U.S. Dividend Equity ETF (SCHD) and the Vanguard Dividend Appreciation ETF (VIG) are two popular dividend ETFs, but they are built for d...
Boston Scientific Stock (BSX) Slides as Cyberattack Set to Batter Full-Year Profits
Shares in medical technology group Boston Scientific ($BSX) slumped nearly 3% in pre-market trading after it said that last month’s cyberattack on ...
Boston Scientific Stock (BSX) Plunges After Global Cybersecurity Incident
Shares in medical technology group Boston Scientific ($BSX) dipped over 3% in pre-market trading after it revealed it had been hit by a major cyber...
Pfizer vs. Abbott: Which Dividend Healthcare Stock Offers the Better Risk-Reward?
Pfizer Inc. (NYSE:PFE) and Abbott Laboratories (NYSE:ABT) offer investors two very different dividend stories.
Hedge Fund Resource Center